Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients

NCT00812032 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT00812032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00812032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients
Lead sponsor
Karolinska Institutet
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
October 31, 2010
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus